Randomized, Double Blind, Positive- Controlled, Three-way Cross-over Human Experimental Biomarker Study of V116517 in Healthy Male Subjects

Trial Profile

Randomized, Double Blind, Positive- Controlled, Three-way Cross-over Human Experimental Biomarker Study of V116517 in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Mar 2016

At a glance

  • Drugs V 116517 (Primary) ; Capsaicin; Celecoxib
  • Indications Pain
  • Focus Pharmacodynamics
  • Sponsors Purdue Pharma L.P
  • Most Recent Events

    • 04 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top